Detalhe da pesquisa
1.
Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma.
Br J Dermatol
; 189(5): 588-602, 2023 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470440
2.
Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors.
Australas J Dermatol
; 63(1): 43-52, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34751431
3.
Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer.
Australas J Dermatol
; 59(4): 302-308, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29349770
4.
Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary Approach.
Cancers (Basel)
; 16(7)2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610956
5.
Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure.
Front Oncol
; 13: 1333098, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38375205
6.
Fear of Cancer Recurrence in Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma.
Int J Radiat Oncol Biol Phys
; 111(4): 890-899, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265396
7.
Symptom burden, quality of life, functioning and emotional distress in survivors of human papillomavirus associated oropharyngeal cancer: An Australian cohort.
Oral Oncol
; 122: 105560, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653749
8.
Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional Study.
Int J Radiat Oncol Biol Phys
; 110(2): 382-393, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33171200
9.
Outcomes of curative (chemo)radiotherapy for patients with non-p16 positive head and neck squamous cell carcinoma who are borderline for curative treatment.
J Med Imaging Radiat Oncol
; 64(2): 271-278, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037733
10.
Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
Pract Radiat Oncol
; 10(1): 29-35, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606546
11.
Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma.
Clin Transl Radiat Oncol
; 21: 85-90, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072029
12.
National survey on image-guided radiotherapy practice in New Zealand.
J Med Imaging Radiat Oncol
; 62(2): 262-269, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29071800
13.
Unilateral radiotherapy treatment for p16/human papillomavirus-positive squamous cell carcinoma of unknown primary in the head and neck.
Laryngoscope
; 128(9): 2076-2083, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481710
14.
Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification.
Int J Radiat Oncol Biol Phys
; 102(4): 941-949, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29730062
15.
Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Head Neck
; 39(4): 772-778, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28199044
16.
Outcomes of Routine Intensity Modulated Radiation Therapy Quality Assurance in a Large Head and Neck Cancer Center.
Int J Radiat Oncol Biol Phys
; 98(3): 541-546, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28581395
17.
Faculty of Radiation Oncology Position Paper on the use of Image-Guided Radiation Therapy.
J Med Imaging Radiat Oncol
; 60(6): 772-780, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27122102
18.
Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Head Neck
; 38 Suppl 1: E1117-21, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26461454
19.
Lessons from malaria screening for newly arrived refugees.
Aust N Z J Public Health
; 30(1): 83-4, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16502957
20.
A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible.
Int J Radiat Oncol Biol Phys
; 76(4): 1066-72, 2010 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19616901